COVID-19 Vaccine (inactivated, adjuvanted) Valneva Unione Europea - italiano - EMA (European Medicines Agency)

covid-19 vaccine (inactivated, adjuvanted) valneva

valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - vaccini - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age.  the use of this vaccine should be in accordance with official recommendations.

Spikevax (previously COVID-19 Vaccine Moderna) Unione Europea - italiano - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaccini - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Jcovden (previously COVID-19 Vaccine Janssen) Unione Europea - italiano - EMA (European Medicines Agency)

jcovden (previously covid-19 vaccine janssen)

janssen-cilag international nv - adenovirus type 26 encoding the sars-cov-2 spike glycoprotein (ad26.cov2-s) - covid-19 virus infection - vaccini - jcovden is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Unione Europea - italiano - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vaccini - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. l'uso di questo vaccino dovrebbe essere in conformità con le raccomandazioni ufficiali.

MONDAK 21 S Italia - italiano - Ministero della Salute

mondak 21 s

syngenta italia s.p.a. - dicamba; - concentrato solubile - 21.2 g i valori indicati sono per 100 g di prodotto. - diserbante

BANVEL 21 S Italia - italiano - Ministero della Salute

banvel 21 s

siapa s.r.l. - dicamba; - concentrato solubile - 21.2 g i valori indicati sono per 100 g di prodotto. - diserbante

SIACIDE 19 L Italia - italiano - Ministero della Salute

siacide 19 l

siapa s.r.l. - metidation; - concentrato emulsionabile - 19.0 g i valori indicati sono per 100 g di prodotto. - insetticida

SIVEL 21 S Italia - italiano - Ministero della Salute

sivel 21 s

siapa s.r.l. - dicamba; - concentrato solubile - 21.2 g i valori indicati sono per 100 g di prodotto. - diserbante

DATIMETHION 19 Italia - italiano - Ministero della Salute

datimethion 19

diachem s.p.a. - metidation; - concentrato emulsionabile - 19.0 g i valori indicati sono per 100 g di prodotto. - insetticida

PYCHLOREX 21,5 CS Italia - italiano - Ministero della Salute

pychlorex 21,5 cs

arysta lifescience benelux sprl - clorpirifos; - concentrato fluido miscibile in oli - 21.5 g i valori indicati sono per 100 g di prodotto. - insetticida